Roche launches Emicizumab for people with Hemophilia A on World Hemophilia Day
It is a first-in-class of treatments for people with severe Hemophilia A, with inhibitors in nearly 20 years
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.